SCHEMBL2005606

SCHEMBL2005606

CCOC(=O)COc1cc(O)c(C(=O)CN2Cc3cc(C(=N)NO)ccc3C2=O)cc1Cl

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.37
PKM P14618 1/20 0.37
PPOX P50336 1/20 0.35
ITGB3 P05106 1/20 0.35
ITGA2B P08514 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
L3MBTL1 Q9Y468 3/20 0.34
AOC3 Q16853 2/20 0.33
ALOX15 P16050 1/20 0.33
MAPT P10636 2/20 0.33
NPSR1 Q6W5P4 1/20 0.33
HPGD P15428 1/20 0.32
ALDH1A1 P00352 2/20 0.32
ADRB3 P13945 2/20 0.32
HMGCR P04035 1/20 0.31
PTPN1 P18031 1/20 0.31
P2RX3 P56373 1/20 0.31
TP53 P04637 1/20 0.31
POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2007548 0.94 ITGB3 (0.37) ITGB3ITGA2BMEN1KMT2AL3MBTL1
SCHEMBL2013514 0.91 ITGB3 (0.35) ITGB3ITGA2BMEN1KMT2AL3MBTL1
SCHEMBL2009815 0.89 ITGB3 (0.34) ITGB3ITGA2BMEN1KMT2AAOC3
SCHEMBL2007658 0.89 ITGB3 (0.34) ITGB3ITGA2BMEN1KMT2AAOC3
SCHEMBL2007042 0.89 GAA (0.37) GAAPKMPPOXITGB3ITGA2B
SCHEMBL2011006 0.89 GAA (0.37) GAAPKMPPOXITGB3ITGA2B
SCHEMBL2006718 0.88 ITGB3 (0.35) GAAPKMPPOXITGB3ITGA2B
SCHEMBL2011867 0.87 GAA (0.38) GAAPKMPPOXITGB3ITGA2B
SCHEMBL2010377 0.86 ITGB3 (0.42) GAAITGB3ITGA2BMEN1KMT2A
SCHEMBL2012100 0.86 HPGD (0.45) GAAITGB3ITGA2BMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7964628-B2 Fibrinogen receptor antagonists and their use PIRAMAL LIFE SCIENCES LIMITED (IN) 2011-06-21 US claimed
US-20100256161-A1 FIBRINOGEN RECEPTOR ANTAGONISTS AND THEIR USE PIRAMAL LIFE SCIENCES LIMITED (IN) 2010-10-07 US claimed
US-7759387-B2 Fibrinogen receptor antagonists and their use PIRAMAL LIFE SCIENCES LIMITED (IN) 2010-07-20 US claimed
US-20070021489-A1 Fibrinogen receptor antagonists and their use NICHOLAS PIRAMAL INDIA LIMITED (IN) 2007-01-25 US claimed
US-7964628-B2 Fibrinogen receptor antagonists and their use PIRAMAL LIFE SCIENCES LIMITED (IN) 2011-06-21 US disclosed
US-20100256161-A1 FIBRINOGEN RECEPTOR ANTAGONISTS AND THEIR USE PIRAMAL LIFE SCIENCES LIMITED (IN) 2010-10-07 US disclosed
US-7759387-B2 Fibrinogen receptor antagonists and their use PIRAMAL LIFE SCIENCES LIMITED (IN) 2010-07-20 US disclosed
US-20070021489-A1 Fibrinogen receptor antagonists and their use NICHOLAS PIRAMAL INDIA LIMITED (IN) 2007-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100256161-A1 FIBRINOGEN RECEPTOR ANTAGONISTS AND THEIR USE FGB, F13B, F2 GAA 3340/4885PKM 3583/4885PPOX 1690/4885
US-20070021489-A1 Fibrinogen receptor antagonists and their use FGB, F13B, F2 GAA 3340/4885PKM 3583/4885PPOX 1690/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.